Janelle Ruisinger

Associate Dean of Academic Affairs
Clinical Professor
Primary office:
KU Medical Center, MS 4047


Dr. Janelle F. Ruisinger is a clinical associate professor at the University of Kansas School of Pharmacy and the director of the KU Community Pharmacy Residency Program. She is also a clinical pharmacist in the KU Medical Center Atherosclerosis and LDL-Apheresis Center which serves as her practice site and primary source for her practice based research.

Ruisinger earned her Pharm.D. degree from the University of Kansas, then completed a PGY1 residency with an emphasis on community care at The Ohio State University College of Pharmacy. She has been with KU School of Pharmacy since 2000.

Courses and Rotations

  • Pharmaceutical Care Fundamentals – coordinator and instructor
  • Pharmacotherapy II - instructor
  • Chemical Dependency elective – co-coordinator
  • Medical Terminology elective – co-coordinator
  • Immunization Theory and Practice – instructor
  • Preceptor for APPE ambulatory care rotation – The KUMC Atherosclerosis and LDL-Apheresis Center
  • Preceptor for 2 community residents in the University of Kansas School of Pharmacy/Balls Food Stores Community Residency Program

Professional Leadership and Service

  • American Pharmacists Association (APhA) Community Pharmacy Residency Program Advisory Panel – appointed a 3 year term March 2011 – March 2014
  • APhA Community Residency Accreditation Practitioner Reviewer, 2008 – present


  • Evaluating the efficacy of alternative therapies for treating dyslipidemia and developing methods to reduce the adverse effects associated with cholesterol agents
  • Conducting practice based research in partnership with community residents

Recent Awards and Honors

  • APhA Distinguished Achievement Award in Pharmacy Practice - 2013
  • University of Kansas School of Pharmacy Preceptor of the Year - Chosen by the class of 2009

Selected Publications

  • Moriarty PM, Backes JM, Ruisinger JF, Schmelzle K, He J, Dutton JA. “Apple Pectin for the Reduction of Niacin-Induced Flushing”. Journal of Clinical Lipidology in press
  • Backes JM, Gibson CA, Ruisinger JF, Moriarty PM. “The High-Dose Rosuvastatin Once Weekly Study (HD-ROWS)”. Journal of Clinical Lipidology 2012; 6:362-367
  • Brna SA, Ruisinger JF, Howard PA, Barnes BJ, Hare SE,  Study of nonparticipation in an employee diabetes program J Am Pharm Assoc. 2012;52:e105-e108
  • Dodson SE, Ruisinger JF, Howard PA, Hare SE, Barnes BJ. Community pharmacy-based medication therapy management services: financial impact for patients. Pharmacy Practice (Internet) 2012 Jul-Sep;10(3):119-124.
  • Backes JM, Gibson CA, Ruisinger JF, Moriarty PM. Modified-Policosanol Does Not Reduce Plasma Lipoproteins in Hyperlipidemic Patients when Used Alone or in Combination with Statin Therapy.  Lipids 2011 Oct;46(10):923-9
  • Ruisinger JF, Koerner JM, Backes JM, Moriarty PM. Supratherapeutic Response to Ezetimibe in a Statin Intolerant Patient. Hospital Pharmacy 2010;45:45-48

Selected Presentations

  • Schuessler B, Ruisinger JF, Grauer, DW, Moriarty PM, Backes JM. “Comparison of vitamin D dosing regimens in non-obese and obese patients with low vitamin d levels”. The American College of Clinical Pharmacy Annual Meeting, October 22nd, 2012 Hollywood, FL (poster presentation)
  • Moriarty PM, Gibson CA, Backes JM, Eldringhoff D, Powell S, Ruisinger JF. The effect of aggressive cardiovascular treatment on the progression of carotid intima-media thickness: Experience of an atherosclerosis prevention center. 79th European Atherosclerosis Society Congress Gothenburg, Sweden, June 26 - 29, 2011 (poster presentation)
  • “Good to Great” PGY1 Community Pharmacy Residency Programs Continuing Education Session invited CE program presented at the APhA Annual Meeting and Exposition, New Orleans, LA. March 11, 2012
  • “Interdisciplinary Research in a Clinical Setting: From Fruits to Nuts, alternative methods in treating atherosclerosis and dyslipidemia”. Internal Medicine Grand Rounds (CE). University of Kansas Medical Center. August 10th, 2011 (Co-presented with Patrick Moriarty, MD and Jim Backes, PharmD)
  • “Good to Great” PGY1 Community Pharmacy Residency Programs Continuing Education Session invited CE program presented at the APhA Annual Meeting and Exposition, Seattle, WA. March 27, 2011

2nd among all schools of pharmacy in National Institutes of Health funding
Brings more than $20 million in external funding into the state each year
7 of 19 cancer drugs formulated through the National Cancer Institute were developed at the KU School of Pharmacy
3,000 free flu shots given to Kansans in need during the past 5 years
4,000 living alumni, 63 percent of them living and working in Kansas
KU pharmacists practice in 95 of Kansas’ 105 counties
20th among public schools of pharmacy.
—U.S. News & World Report
$20.2 million NIH research grant earned by Distinguished Professor Jeff Aubé was 2nd largest in Kansas history
100 percent placement after graduation for KU Pharm.D. students
Established in 1885 as the 1st professional program at KU
KU Today